American Regent, Inc. — Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN

Official product recall notices and clearly labeled enforcement reference records.

Reference record — not a live warning · enforcement-reference · official-source

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Provider: FDA — drug enforcement reference
Source observed: 8/26/2026, 12:00:00 AM UTC
Source updated: 8/26/2026, 12:00:00 AM UTC
Location: Shirley, NY, US
hazard: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
notice: Periodic enforcement reference; not a real-time safety alert or a reliable recall-lifecycle tracker.
product: Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
distribution: Nationwide within the U.S
manufacturer: American Regent, Inc.
recall number: D-0800-2026
source status: Ongoing
classification: Class I
freshness minutes: 180

Source use policy · openFDA reference data; not a real-time public alert service

Update history (1 recent revisions)